Branchout Food Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Branchout Food Inc. (Nasdaq: BOF) on October 15, 2024, reporting events occurring on October 10, 2024, and October 14, 2024. The filing addresses a critical delisting determination by The Nasdaq Stock Market and the results of the Company's 2024 Annual Meeting of Stockholders.
Key Financial Metrics
The filing references historical financial data regarding stockholders' equity but does not provide current revenue, profit, cash flow, or debt metrics for the reporting period.
- Stockholders' Equity: $2,210,476 as of December 31, 2023 (reported in the April 1, 2024 Form 10-K).
- Nasdaq Minimum Requirement: $2,500,000.
- Compliance Status: The Company failed to meet the minimum equity requirement and subsequently failed to meet the terms of its 180-day compliance extension.
Material Changes and Events
Delisting Determination: On October 10, 2024, Nasdaq notified the Company that it did not meet the terms of its extension to regain compliance with Listing Rule 5550(b)(1) regarding minimum stockholders' equity. Without an appeal, trading would have been suspended on October 21, 2024, and the stock removed from Nasdaq.
Appeal Filed: On October 11, 2024, the Company submitted a request for a hearing with Nasdaq's Hearings Panel. This action stays the suspension of trading and the filing of the Form 25-NSE pending the Panel's decision.
Annual Meeting Results: On October 14, 2024, stockholders representing 63.7% of outstanding shares voted on seven proposals. All proposals were approved, including:
- Election of six director nominees.
- Approval of the full conversion of a 12% Senior Secured Convertible Promissory Note issued to Kaufman Kapital LLC.
- Approval of the full exercise of warrants issued to Kaufman Kapital LLC (1,500,00 shares).
- Approval of the full exercise of warrants issued to Eric Healy (865,536 shares).
- Ratification of M&K CPAS, PLLC as independent auditors.
Outlook, Risks, and Contingencies
Delisting Risk: The primary risk is the potential removal of the Company's securities from the Nasdaq Capital Market if the Hearings Panel upholds the delisting determination. The outcome of the appeal is pending.
Dilution Risk: The approval of the conversion of the Convertible Note and the exercise of warrants by Kaufman Kapital and Eric Healy will result in the issuance of new shares, which may dilute existing shareholders.
Management Commentary: The filing does not contain forward-looking guidance or management commentary regarding future financial performance beyond the procedural steps taken to address the delisting notice.
Investor Verification Checklist
- Verify the status of the Nasdaq Hearings Panel decision regarding the delisting appeal.
- Confirm the exact number of shares to be issued upon the conversion of the Kaufman Kapital Note and the exercise of the approved warrants.
- Review the definitive Proxy Statement filed on September 9, 2024, for details on the terms of the Convertible Note and warrant exercises.
- Monitor for any subsequent filings (e.g., Form 25-NSE) if the appeal is unsuccessful.